The WHO released new guidance on GLP-1 medications for adults with obesity, recommending their long-term, continuous use when ...

The health agency supports the long-term use of the medications in combination with a healthy diet and exercise, and calls ...

The WHO issued guideline on the use of GLP-1 therapies for obesity, conditionally recommending them as part of long-term treatment.

Despite making progress in educating people, social stigma and taboo still exist. Hence, the day becomes significant in ...

The World Health Organization (WHO) has finally made its recommendations on using glucagon-like peptide-1 (GLP-1) ...

Ozempic-style medications have been recommended as long-term treatments for obesity under new guidelines released by the ...

The WHO also recommends that health services should aim to strengthen physical care for people with mental illnesses, since ...

A new generation of appetite-suppressing drugs called GLP-1 agonists - which includes blockbuster brands Ozempic and Mounjaro ...

The University of Washington School of Medicine (UWSOC) doctors have been noticing a trend among some chronic cannabis users.

Thirty-eight-year-old Rosy Devi’s body aches most of the time, short walks have become difficult, she loses her breath easily, has chest pain and feels her health is generally getting worse. It has ...

"I will permanently pause migration from all Third World Countries to allow the U.S. system to fully recover," he wrote on ...

A group of independent vaccine advisers to the US Centers for Disease Control and Prevention is meeting this week, and a key ...